SEC
Filing

SEC Filing Details

Document Details

Form
8-K
Filing Date
Sep 4, 2018
Document Date
Sep 4, 2018
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Altimmune
Issuer
ALTIMMUNE, INC.
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe